Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Apr 2023
The FNB Head and Neck Oncology curriculum was made public by the National Board of Examinations (NBE). I. Head and neck. INTRODUCTION (BACKGROUND).
Read Full NewsThe phase 3 HARMONIA trial will evaluate whether a muscle- and CNS-targeted antisense conjugate improves function across multiple systems in patients with myotonic dystrophy type 1.
New data from the 2026 AANEM Annual Meeting showed zilucoplan delivered via autoinjector was bioequivalent to the pre-filled syringe and was well tolerated when self-administered by patients with generalized myasthenia gravis.
The ongoing phase 3 study is enrolling approximately 180 adults across more than 13 countries, with topline results expected in mid-2027.
EpilepsyGTx and Viralgen have entered a manufacturing collaboration to support development of EPY201, an investigational AAV9-based gene therapy for focal refractory epilepsy planned to enter first-in-human testing in 2027.
Phase 3 trials EMNERGIZE and EMVIGORATE will evaluate the efficacy and safety of intravenous empasiprubart in adults with chronic inflammatory demyelinating polyradiculoneuropathy.
The chairman of the Neurology Service Line at Baptist Health in Kentucky discussed PREVIEW trial findings for gefelorilimab in generalized myasthenia gravis, including efficacy, safety, and what the subcutaneous C5 inhibitor could offer patients if approved.
Lessons From 10,000 Organ Transplants, With Ari Cohen, MD
1.
Similar survival seen with simple versus radical hysterectomy for cervical cancer
2.
Launch of the hereditary cancer clinic for precision oncology at Kokilaben Hospital.
3.
Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening
4.
Induction Immunotherapy Has Durable Survival Benefit in LACC
5.
Simultaneously targeting lysosomal enzyme and KRAS-MAPK pathway eradicates pancreatic tumors in preclinical models
1.
Oncologic Emergencies: Diagnosis and Treatment
2.
Therapeutic RNA Vaccines for Cancer: Mechanisms, Clinical Applications, and Future Directions
3.
The Immunotherapeutic and Targeted Revolution in Melanoma Management – A 2025 Perspective
4.
Modern Developments in Oncology for Specialists
5.
Contemporary Approaches in Hematology for Specialists
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
The Role of Hemoglobin in Maintaining Healthy Oxygen Levels
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- The Conclusion
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge